thiazoles has been researched along with osi 027 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altman, JK; Beauchamp, EM; Bliss-Moreau, M; Blyth, G; Colamonici, M; Giles, FJ; Platanias, LC; Saleiro, D; Szilard, A | 1 |
| Beauchamp, EM; Bell, JB; Blyth, GT; Clymer, J; Eckerdt, F; Goldman, S; Platanias, LC | 1 |
2 other study(ies) available for thiazoles and osi 027
| Article | Year |
|---|---|
Dual targeting of acute myeloid leukemia progenitors by catalytic mTOR inhibition and blockade of the p110α subunit of PI3 kinase.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Class I Phosphatidylinositol 3-Kinases; Enzyme Inhibitors; Humans; Imidazoles; Leukemia, Myeloid, Acute; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Triazines; U937 Cells | 2015 |
Pharmacological mTOR targeting enhances the antineoplastic effects of selective PI3Kα inhibition in medulloblastoma.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Cell Nucleus; Class I Phosphatidylinositol 3-Kinases; Female; Humans; Imidazoles; Medulloblastoma; Mice, Nude; Protein Kinase Inhibitors; Sarcoma, Ewing; Signal Transduction; Thiazoles; TOR Serine-Threonine Kinases; Triazines; Xenograft Model Antitumor Assays; Zinc Finger Protein GLI1 | 2019 |